More Tumor Mutations Equals Higher Success Rate With Cancer Immunotherapy Drugs – Anti Aging News
|
More Tumor Mutations Equals Higher Success Rate With Cancer Immunotherapy Drugs
Anti Aging News The “mutational burden,” or the number of mutations present in a tumor's DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel … |
